Global Treatment for Syndromes of Dementia and Movement Disorders Market is Estimated to Reach $28.6 Billion by 2024 - PowerPoint PPT Presentation

About This Presentation
Title:

Global Treatment for Syndromes of Dementia and Movement Disorders Market is Estimated to Reach $28.6 Billion by 2024

Description:

Global Treatment for Syndromes of Dementia and Movement Disorders Market is estimated to reach $28.6 Billion by 2024; growing at a CAGR of 8.9% from 2016 to 2024. Dementia is basically an assortment of symptoms triggered by disorders affecting the brain. – PowerPoint PPT presentation

Number of Views:32

less

Transcript and Presenter's Notes

Title: Global Treatment for Syndromes of Dementia and Movement Disorders Market is Estimated to Reach $28.6 Billion by 2024


1
Global Treatment for Syndromes of Dementia and
Movement Disorders Market is Estimated to Reach
28.6 Billion by 2024
Dinesh Patel SEO Analyst help_at_variantmarketresear
ch.com
sale_at_variantmarketresearch.com
help_at_variantmarketresearch.com
2
DESCRIPTION Treatment for Syndromes of
Dementia and Movement Disorders Market
Global Treatment for Syndromes of Dementia and
Movement Disorders Market is estimated to reach
28.6 Billion by 2024 growing at a CAGR of 8.9
from 2016 to 2024. Dementia is basically an
assortment of symptoms triggered by disorders
affecting the brain. Dementia majorly affects
thinking capability, and ability to perform
day-to-day tasks. Dementia and movement disorders
are caused due to brain damages instigated by
diseases or a series of strokes. Persons above
the age of 65 years are more prone to be affected
by these disorders. According to World Alzheimer
Report 2015, 46 million people are suffering from
dementia and the number is expected to rise to
131.5 million by 2050. Browse Complete Report _at_
https//www.variantmarketresearch.com/report-categ
ories/pharmaceuticals/treatment-for-syndromes-of-d
ementia-and-movement-disorders-market
sale_at_variantmarketresearch.com
help_at_variantmarketresearch.com
3
Treatment for Syndromes of Dementia and Movement
Disorders Market Size and Forecast
sale_at_variantmarketresearch.com
help_at_variantmarketresearch.com
4
Treatment for Syndromes of Dementia and Movement
Disorders Market
The global treatment for syndromes of dementia
and movement disorders market is categorized into
type and geography. By type, the segment is
categorized into movement disorders (Parkinsons
disease, progressive supranuclear palsy, multiple
system atrophy, hallervorden-spatz disease and
others), progressive dementia (Alzheimers
disease, Lewy body dementia, frontotemporal
dementia/pick and others) and progressive
dementia with neurological abnormality
(Huntingtons disease, corticobasal ganglionic
degeneration, amyotrophic lateral
sclerosis(ALS)) Get Sample Report _at_
https//www.variantmarketresearch.com/report-categ
ories/pharmaceuticals/treatment-for-syndromes-of-d
ementia-and-movement-disorders-market/sample-reque
st
sale_at_variantmarketresearch.com
help_at_variantmarketresearch.com
5
Treatment for Syndromes of Dementia and Movement
Disorders Market share by region
sale_at_variantmarketresearch.com
help_at_variantmarketresearch.com
6
MAJOR KEY PLAYERS
  •  Valeant Pharmaceutical International
  • AstraZeneca GmbH
  • F. Hoffmann-La Roche
  • AG
  • Abbott Laboratories, Inc.
  • Merck Co., Inc.
  • Sanofi S.A.
  • Novartis AS
  • Bristol-Myers Squibb
  • Baxter International Inc.
  • Pfizer Inc.

sale_at_variantmarketresearch.com
help_at_variantmarketresearch.com
7
The Key Takeaways From The Report
  • The report will provide a detailed analysis of
    Global Treatment for Syndromes of Dementia and
    Movement Disorders Market with respect to major
    segments such as type, and geography
  • The report will include the qualitative and
    quantitative analysis with market estimation over
    2015-2024 and compound annual growth rate (CAGR)
    between 2016 and 2024
  • Comprehensive analysis of market dynamics
    including factors and opportunities will be
    provided in the report
  • An exhaustive regional analysis of Global
    Treatment for Syndromes of Dementia and Movement
    Disorders Market from 2015 to 2024 has been
    included in the report
  • Profile of the key players in the Global
    Treatment for Syndromes of Dementia and Movement
    Disorders Market will be provided, which include
    key financials, product services, new
    developments and business strategies

sale_at_variantmarketresearch.com
help_at_variantmarketresearch.com
8
Scope of the Global Treatment for Syndromes of
Dementia and Movement Disorders Market
  • Type Segments
  • Movement Disorders
  • Parkinsons Disease
  • Progressive Supranuclear Palsy
  • Multiple System Atrophy
  • Hallervorden-Spatz Disease
  • Others 

sale_at_variantmarketresearch.com
help_at_variantmarketresearch.com
9
Scope of the Global Treatment for Syndromes of
Dementia and Movement Disorders Market
  • Progressive Dementia
  • Alzheimers Disease
  • Lewy Body Dementia
  • Frontotemporal Dementia/Pick
  • Others
  • Progressive Dementia with Neurological
    Abnormality (PDNA)
  • Huntingtons Disease
  • Corticobasal Ganglionic Degeneration
  • Amyotrophic Lateral Sclerosis (ALS)

sale_at_variantmarketresearch.com
help_at_variantmarketresearch.com
10
Table Of Content
Chapter 1 Prefix 1.1 Market Scope 1.2
Report Description 1.3 Research Methodology
1.3.1 Primary Research 1.3.2
Secondary Research 1.3.3 In-house Data
Modeling Chapter 2 Executive Summary
sale_at_variantmarketresearch.com
help_at_variantmarketresearch.com
11
Table Of Content
Chapter 3 Market Outline 3.1 Market
Inclination, Trend, Outlook and Viewpoint 3.2
Market Share Analysis Companys Competitive
Scenario 3.3 Value Chain Analysis 3.4
Market Dynamics 3.4.1 Drivers
3.4.1.1 Impact Analysis 3.4.2
Restraints 3.4.2.1 Impact
Analysis 3.4.3 Opportunities 3.5
Porters five forces analysis 3.5.1
Factors Impact Analysis
sale_at_variantmarketresearch.com
help_at_variantmarketresearch.com
12
Table Of Content
Chapter 6 Company Profiles 6.1 Valeant
Pharmaceutical International 6.2 AstraZeneca
GmbH 6.3 F. Hoffmann-La Roche, AG 6.4
Abbott Laboratories, Inc. 6.5 Merck Co.,
Inc. 6.6 Sanofi S.A. 6.7 Novartis AG
6.8 Bristol-Myers Squibb 6.9 Baxter
International, Inc. 6.10 Pfizer, Inc.
sale_at_variantmarketresearch.com
help_at_variantmarketresearch.com
13
CONTACT US
VARIANT MARKET RESEARCH LLP Web
https//www.variantmarketresearch.com Address
649 Mission St.,5th Floor, San Francisco, CA
94105, United States. Tel 1-415-680-2785 Fax
1-415-680-2786 Email help_at_variantmarketresearch
.com
14
THANK YOU .
Sample Request
FOLLOW US
Google Plus
LinkedIn
Twitter
Facebook
sale_at_variantmarketresearch.com
help_at_variantmarketresearch.com
Write a Comment
User Comments (0)
About PowerShow.com